Dragan Cicic
Fortuna: 1 M $ al 31/05/2026
Fortuna: 1 M $ al 31/05/2026
Dragan Cicic is currently a Member at the American Society of Hematology and Chief Development Officer & Senior Vice President at SELLAS Life Sciences Group, Inc. since 2024.
Former positions include Director, Chief Operating & Medical Officer at Actinium Pharmaceuticals, Inc. (2012–2013), Project Director at QED Technologies International, Inc., Chief Operating & Medical Officer at Cactus Ventures, Inc. (2012–2013), Principal at British Broadcasting Corp., Chief Technology Officer at Actinium Pharmaceuticals, Inc. (2017), and Senior Vice President at KLUS Pharma, Inc. Education includes a doctorate from the University of Belgrade, an MBA from The Wharton School of the University of Pennsylvania, and a doctorate from the School of Medicine (RS).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/04/2026 | 126.443 ( 0,07 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Corporate Officer/Principal | - |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Director Ejecutivo | - |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Director Técnico/Científico/I+D | 18/04/2013 |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Director de Operaciones | 18/04/2013 |
KLUS Pharma, Inc.
KLUS Pharma, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel and safer antibody-based therapeutics | Corporate Officer/Principal | - |
British Broadcasting Corp.
British Broadcasting Corp. BroadcastingConsumer Services Provides television and radio broadcasting & digital media services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and commercializes alpha particle immunotherapeutics | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
British Broadcasting Corp.
British Broadcasting Corp. BroadcastingConsumer Services Provides television and radio broadcasting & digital media services | Consumer Services |
University of Belgrade
University of Belgrade Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QED Technologies International, Inc.
QED Technologies International, Inc. SemiconductorsElectronic Technology Develops polishing and metrology technology for semiconductors | Electronic Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
School of Medicine (RS)
School of Medicine (RS) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
KLUS Pharma, Inc.
KLUS Pharma, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel and safer antibody-based therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.